|
Volumn 9, Issue 10, 2014, Pages 1799-1801
|
Filling the holes in cystic kidney disease research
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
FIBROCYSTIN;
POLYCYSTIN 1;
POLYCYSTIN 2;
SOMATOSTATIN DERIVATIVE;
VASOPRESSIN RECEPTOR ANTAGONIST;
GENETIC MARKER;
ARTICLE;
CALCIUM SIGNALING;
CARDIOVASCULAR DISEASE;
CELL PROLIFERATION;
DISEASE COURSE;
GENE;
GENE INACTIVATION;
GENE MUTATION;
GENETIC HETEROGENEITY;
GLOMERULUS FILTRATION RATE;
HUMAN;
HYPERTENSION;
KIDNEY CYST;
KIDNEY FAILURE;
KIDNEY FIBROSIS;
KIDNEY POLYCYSTIC DISEASE;
LIVER DISEASE;
LIVER FIBROSIS;
MORBIDITY;
MORTALITY;
NEPHRITIS;
PATIENT CARE;
POLYCYSTIC KIDNEY DISEASE 1 GENE;
POLYCYSTIC KIDNEY DISEASE 2 GENE;
RISK;
ANIMAL;
GENETIC MARKER;
GENETIC PREDISPOSITION;
GENETICS;
HEALTH CARE PLANNING;
MASS COMMUNICATION;
MEDICAL RESEARCH;
NEPHROLOGY;
PATHOPHYSIOLOGY;
PHENOTYPE;
POLYCYSTIC KIDNEY DISEASES;
PREDICTIVE VALUE;
PROGNOSIS;
RISK ASSESSMENT;
RISK FACTOR;
TRENDS;
ANIMALS;
BIOMEDICAL RESEARCH;
DIFFUSION OF INNOVATION;
GENETIC MARKERS;
GENETIC PREDISPOSITION TO DISEASE;
HEALTH PRIORITIES;
HUMANS;
NEPHROLOGY;
PHENOTYPE;
POLYCYSTIC KIDNEY DISEASES;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
RISK ASSESSMENT;
RISK FACTORS;
|
EID: 84911438013
PISSN: 15559041
EISSN: 1555905X
Source Type: Journal
DOI: 10.2215/CJN.03410414 Document Type: Article |
Times cited : (8)
|
References (2)
|